so DTL have gone from moving $3 million from FY21 to FY22 and now $6 million from FY22 to FY23. That has to be a positive for future profits. I can see a time, maybe FY24 when no deferred profit is move to the next FY the profits in the year could be negative to flat at best?
- Forums
- ASX - By Stock
- Ann: DTL to deliver strong FY22 performance
so DTL have gone from moving $3 million from FY21 to FY22 and...
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add DTL (ASX) to my watchlist
(20min delay)
|
|||||
Last
$7.40 |
Change
-0.120(1.60%) |
Mkt cap ! $1.146B |
Open | High | Low | Value | Volume |
$7.55 | $7.58 | $7.40 | $3.620M | 486.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
13 | 23725 | $7.40 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$7.46 | 2262 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
13 | 23725 | 7.400 |
4 | 2816 | 7.390 |
2 | 3697 | 7.380 |
2 | 4197 | 7.370 |
2 | 3646 | 7.360 |
Price($) | Vol. | No. |
---|---|---|
7.460 | 2262 | 1 |
7.470 | 2262 | 1 |
7.480 | 2262 | 1 |
7.620 | 725 | 3 |
7.670 | 1350 | 1 |
Last trade - 16.10pm 10/10/2024 (20 minute delay) ? |
Featured News
DTL (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online